30.Kumar A, Chen F, Mozhi A, Zhang X, Zhao Y, Xue X, Hao Y, Zhang X, Wang PC, Liang XJ*.Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.Nanoscale2013

29.Shikui Wu, Chaojun Chen, Xiaoping Shen, Gang Li, Lina Gao, Amei Chen, Jinfeng Hou and Xingjie Liang.One-pot synthesis, formation mechanism and near infrared fluorescent properties of hollow and porous a-mercury sulfide.CrystEngComm.2013

28.Beatriz Pelaz, Gaëlle Charron, Christian Pfeiffer, Yuliang Zhao, Jesus M. de la Fuente, Xing-Jie Liang, Wolfgang J. Parak, and Pablo del Pino*.Interfacing Engineered Nanoparticles with Biological Systems: Anticipating Adverse Nano-Bio Interactions. Small.2013

27.Pilar Rivera_Gil, Dorleta Jimenez De Aberasturi, Verena Wulf, Beatriz Pelaz, Pablo Del Pino, Yuanyuan Zhao, Jesus De La Fuente, Idoia Ruiz De Larramendi, Teófilo Rojo, Xing-Jie Liang, Wolfgang J. Parak.The challenge to relate physico-chemical properties of colloidal nanoparticles to their cytotoxicity.Accounts of Chemical Research.2013.46(3):743-749.

26.Xue Xue, Matthew Hall, Qiang Zhang, Paul Wang, Michael M Gotteman, Xing-Jie Liang*.Nanoscale Drug Delivery Platforms Overcome Platinum-Based Resistance in Cancer Cells Due to Abnormal Membrane Protein Trafficking.ACS Nano.2013.7(12):10452–10464

25.Yuanyuan Zhao, Xu Zhang, Xiangdong Xue, Zhipeng Li, Fei Chen, Shengliang Li, Anil Kumar, Guozhang Zou*, and Xing-Jie Liang*.High Throughput Detection of Human Neutrophil Peptides from Serum, Saliva and Tear by Anthrax Lethal Factor-Modified Nanoparticles.ACS Applied Materials & Interfaces.2013.5(17):8267-8272.

24.Anil Kumar, Xu Zhang, Xing-Jie Liang*.Gold Nanoparticles: Emerging Paradigm for Targeted Drug Delivery System.Biotechnology Advances.2013.31:593-606.

23.Shubin Jin, Xiaowei Ma, Huili Ma, Kaiyuan Zheng, Juan Liu, Shuai Hou, Jie Meng, Paul C. Wang, Xiaochun Wu * and Xing-Jie Liang *.Long genomic DNA amplicons adsorption onto unmodified gold nanoparticles for colorimetric detection of Bacillus anthracis.Nanoscale.2013.5:143-146.

22.Hua Deng, Xu Zhang, Anil Kumar, Guozang Zou , Xiaoning Zhang *and Xing-Jie Liang *.Long genomic DNA amplicons adsorption onto unmodified gold nanoparticles for colorimetric detection of Bacillus anthracis. Chemical Communication.2013.49:51-53.

21.Wendi Zhang,Qiang Cheng,Shutao Guo,Daoshu Lin,Pingsheng Huang,Juan Liu,Tuo Wei,Liandong Deng,Zicai Liang,Xingjie Liang,Anjie Dong.Gene transfection efficacy and biocompatibility of polycation/DNA complexes coated with enzyme degradable PEGylated hyaluronic acid.Biomaterials.2013.pdf

20.Tuo Wei,Juan Liu,Huili Ma,Qiang Cheng,Yuanyu Huang,Jing Zhao,Shuaidong Huo,Xiangdong Xue,Zicai Liang,Xingjie Liang.Functionalized Nanoscale Micelles Improve Drug Delivery for Cancer Therapy in Vitro and in Vivo.Nano letters.2013, 13 (6), pp 2528–2534.pdf

18. Farzin Haque, Jinghong Li, Hai-Chen Wu, Xing-Jie Liang, and Peixuan Guo. Solid-state and biological nanopore for real-time sensing of single chemical and sequencing of DNA. Nano Today.2013. 8(1): 56-74.pdf

17. Xixue Hu, Xiaohong Hao, Yan Wu, Jinchao Zhang, Xiaoning Zhang, Paul C Wang, Guozhang Zou, Xing-Jie Liang*. Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dually response. J. Mater. Chem.2013. 1: 1109-1118.pdf

16. Kangning Yang, Weipeng Cao, Xiaohong Hao, Xue Xue, Jing Zhao, Juan Liu, Yuliang Zhao, Jie Meng, Baoyun Sun, Jinchao Zhang, Xing-Jie Liang.* Metallofullerene Nanoparticles Promote Osteogenic Differentiation of Bone Marrow Stromal Cells through BMP Signaling Pathway. Nanoscale.2013. 5 (3), 1205 – 1212.pdf

15. Lee Jia. Yusheng Lu, Jingwei Shao, Xing-Jie Liang, Yan Xu. Nanoproteomics: a new sprout from emerging links between nanotechnology and proteomics. Trends in Biotechnology.2013. 31(2): 99-107.pdf

14. Qiang Cheng, Yuanyu Huang, Hua Zheng, Tuo Wei, Shuquan Zheng, Shuaidong Huo, Xiaoxia Wang, Quan Du, Xiaoning Zhang, Hong-Yan Zhang, Xing-Jie Liang, Chun Wang, Rupei Tang, Zicai Liang. The effect of Guanidinylation of PEGylated Poly(2-aminoethyl methacrylate) on the Systemic Delivery of siRNA. Biomaterials.2013. 34(12):3120-3131.pdf

13. Jie Meng*, Xing-Jie Liang, Xiaoyuan Chen, Yu-Liang Zhao. Biological characterizations of [Gd@C82(OH)22]n nanoparticles as fullerene derivatives for cancer therapy. Integrative Biology.2013. 5(1):43-47.pdf

12.Liming Hu, Yun Sun, Shengliang Li, Xiaoli Wang, Kelei Hu, Lirong Wang, Xing-jie Liang, Yan Wu.Multifunctional carbon dots with high quantum yield for imaging and gene delivery.Carbon.2013.67:508-513.

11.Zhang Jinchao, Yang Kangning, Zhang Haisong, Liang Xingjie.Application Status and Prospect of Carbon-Based Nanomaterials in the Biomedical Field.Progress in Chemistry.2013.25(2):397-408.

10.Shizhu Chen, Qun Zhang, Yingjian Hou, Chunyan Dai , Jinchao Zhang, and Xing-Jie Liang*.Nanomaterials in medicine and pharmaceuticals: nanoscale materials developed with less toxicity and more efficacy.European Journal of Nanomedicine.2013.5(2):61-79.

9.Xuehua Ma, An Gong, Lingchao Xiang, Tianxiang Chen, Yuexia Gao, Xingjie Liang, Zheyu Shen* and Aiguo Wu*.Biocompatible composite nanoparticles with large longitudinal relaxivity for targeted imaging and early diagnosis of cancer.Journal of Materials Chemistry B.2013.1:3419-3428.

8.Shuaidong Huo, Shubin Jin, Kaiyuan Zheng, Shengtai He, Dongliang Wang* & Xing-Jie Liang*.Preparation and characterization of doxorubicin functionalized tiopronin-capped gold nanorods for cancer therapy.Chinese Science Bulletin.2013.58 (33):4072-4076.

7.吕晓蓉，李 超，王东亮， 许海燕， 梁 伟， 吴树仙， 郭大军* 梁兴杰*. 纳米药物研究国际发展态势. 科学观察.2013.8(3):53-57.

6.霍帅东，王东亮，甘雅玲，梁兴杰*. 聚乙二醇稳定的单分散超小金纳米颗粒的制备与表征. 电子显微学报.2013.32(5):378-382.

5.霍帅东, 金叔宾, 郑凯元, 何声太, 王东亮*, 梁兴杰*. 一种用于癌症治疗的硫普罗宁包被载阿霉素的金纳米棒的制备与表征. 科学通报.2013.58(24):2495-2500.

4.梁兴杰, 张欣. 纳米生物医学 一个交叉学科新前沿. 生物化学与生物物理进展.2013.40(10):891.

3.胡笑梅， 黄渝然， 薛雪， 赵元元，庄小溪， 梁兴杰* 杨静玉. 基于肿瘤异常结构的纳米药物设计. 生物化学与生物物理进展.2013.40(10):990-997.

2.郝晓红， 张翠妙， 刘小龙， 梁兴杰，贾光， 张金超.  基于介孔二氧化硅的多功能纳米药物输送体系研究进展.  生物化学与生物物理进展.2013.40(10):1014-1022.

1.张 博， 吕晓蓉，吴树仙， 张小宁， 侯仰龙， 郭大军* 梁兴杰*. 国际纳米药物领域专利态势分析. 科学观察.2013.8(3):58-63.